Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary

Pathol Oncol Res. 2024 Mar 21;30:1611758. doi: 10.3389/pore.2024.1611758. eCollection 2024.ABSTRACT[This corrects the article DOI: 10.3389/pore.2024.1611497.].PMID:38576767 | PMC:PMC10991778 | DOI:10.3389/pore.2024.1611758

Source: Pathology Oncology Research - April 5, 2024 Category: Pathology Authors: Peter Batar Hussain Alizadeh Gyorgy Rokszin Zsolt Abonyi-Toth Judit Demeter Source Type: research